BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18196642)

  • 1. [Introduction of adrenergic beta-blockers into medical therapy].
    Varagić VM
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():1-4. PubMed ID: 18196642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Adrenergic blockers: a 50-year historical perspective.
    Frishman WH
    Am J Ther; 2008; 15(6):565-76. PubMed ID: 19127141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish.
    Owen SF; Giltrow E; Huggett DB; Hutchinson TH; Saye J; Winter MJ; Sumpter JP
    Aquat Toxicol; 2007 May; 82(3):145-62. PubMed ID: 17382413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain on itself: Nobel laureates and the history of fundamental nervous system function.
    Langmoen IA; Apuzzo ML
    Neurosurgery; 2007 Nov; 61(5):891-907; discussion 907-8. PubMed ID: 18091266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology.
    Stapleton MP
    Tex Heart Inst J; 1997; 24(4):336-42. PubMed ID: 9456487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on beta blockers.
    Williams JR
    AANA J; 1989 Feb; 57(1):29-36. PubMed ID: 2564714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-blockers. Results of utilization in various areas of medicine. Pharmacotherapy symposium held at Sava Center 11 July 1992 organized by the Pharmacotherapy Section of the Serbian Medical Society].
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():1-80. PubMed ID: 18348355
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis: headaches that never happen.
    Loder E
    Headache; 2008 May; 48(5):694-6. PubMed ID: 18471113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and endogenous beta-adrenergic receptor antagonists--comparative pharmacological characterization.
    Temnyalov ND
    Auton Neurosci; 2009 Jun; 148(1-2):16-20. PubMed ID: 19328045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [40 years beta-adrenoceptor blockers in psychiatry].
    Kornischka J; Cordes J; Agelink MW
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):199-210. PubMed ID: 17200914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy in patients with stable coronary artery disease treated on an outpatient basis in Poland. Results of the multicentre RECENT study.
    Banasiak W; Wilkins A; Pociupany R; Ponikowski P
    Kardiol Pol; 2008 Jun; 66(6):642-9; discussion 650. PubMed ID: 18626833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of beta-blockers with particular reference to hypertension].
    Kocijancić M
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():10-6. PubMed ID: 18193806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical pharmacology: turning our pharmacological models upside down.
    Page C
    Trends Pharmacol Sci; 2011 Apr; 32(4):197-200. PubMed ID: 21458081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The 2008 Nobel Prizes in medicine and physiology].
    Valdespino JL; Ponce-de-León S; de Lourdes Garcia M
    Gac Med Mex; 2009; 145(3):245-8. PubMed ID: 19685833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioneers in cardiology: Sir James Black, MB, ChB, FRS, FRCP. Interview by Mark Nicholls.
    Black J
    Circulation; 2008 Feb; 117(8):f47-8. PubMed ID: 18309531
    [No Abstract]   [Full Text] [Related]  

  • 20. The major impacts of James Black's drug discoveries on medicine and pharmacology.
    Walker MJ
    Trends Pharmacol Sci; 2011 Apr; 32(4):183-8. PubMed ID: 21414672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.